138 related articles for article (PubMed ID: 3250915)
1. [Emetic and catalepsy-inducing actions of buflomedil].
Koda H; Hashimoto T; Kuriyama K
Nihon Yakurigaku Zasshi; 1988 Dec; 92(6):375-9. PubMed ID: 3250915
[TBL] [Abstract][Full Text] [Related]
2. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y
Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775
[TBL] [Abstract][Full Text] [Related]
3. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
Singh A; Naidu PS; Kulkarni SK
Pharmacology; 2003 Jun; 68(2):81-8. PubMed ID: 12711835
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Onodera K; Shinoda H
Agents Actions; 1991 May; 33(1-2):143-6. PubMed ID: 1897431
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of KW-5338 (domperidone) against emesis and depression of intestinal motility induced by L-DOPA.
Shuto K; Shiozaki Z; Kojima T; Tanaka M
J Pharmacobiodyn; 1980 Dec; 3(12):709-14. PubMed ID: 7277186
[TBL] [Abstract][Full Text] [Related]
6. Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
Taniguchi R; Nakagawasai O; Tan-no K; Yamadera F; Nemoto W; Sato S; Yaoita F; Tadano T
Biosci Biotechnol Biochem; 2013; 77(2):266-70. PubMed ID: 23391905
[TBL] [Abstract][Full Text] [Related]
7. KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity.
Kanda T; Shiozaki S; Shimada J; Suzuki F; Nakamura J
Eur J Pharmacol; 1994 May; 256(3):263-8. PubMed ID: 8045270
[TBL] [Abstract][Full Text] [Related]
8. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
Ushijima I; Mizuki Y; Yamada M
Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
[TBL] [Abstract][Full Text] [Related]
9. Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
Koda H; Hashimoto T; Kuriyama K
Jpn J Pharmacol; 1989 Feb; 49(2):215-23. PubMed ID: 2659861
[TBL] [Abstract][Full Text] [Related]
10. [Antiemetic activity of dimetpramid].
Legeza VI; Shagoian MG; Martirosov KS; Kamynina MF; Markovskaia IV
Farmakol Toksikol; 1984; 47(5):55-9. PubMed ID: 6542025
[TBL] [Abstract][Full Text] [Related]
11. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
Johnson AM; Loew DM; Vigouret JM
Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Banasikowski TJ; Beninger RJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats.
Wanibuchi F; Usuda S
Psychopharmacology (Berl); 1990; 102(3):339-42. PubMed ID: 1979179
[TBL] [Abstract][Full Text] [Related]
15. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
Shiozaki S; Ichikawa S; Nakamura J; Kitamura S; Yamada K; Kuwana Y
Psychopharmacology (Berl); 1999 Nov; 147(1):90-5. PubMed ID: 10591873
[TBL] [Abstract][Full Text] [Related]
16. The COMT inhibitor tolcapone potentiates the anticataleptic effect of Madopar in MPP(+)-lesioned mice.
Himori N; Mishima K
Experientia; 1994 Oct; 50(10):939-42. PubMed ID: 7957769
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
18. Dopamine antagonists induce gastric lesions in rats.
Sikirić P; Geber J; Ivanović D; Suchanek E; Gjuris V; Tućan-Foretić M; Mise S; Cvitanović B; Rotkvić I
Eur J Pharmacol; 1986 Nov; 131(1):105-9. PubMed ID: 3816940
[TBL] [Abstract][Full Text] [Related]
19. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
Chiu S; Mishra RK
Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
[TBL] [Abstract][Full Text] [Related]
20. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Maj J; Rogóz Z; Skuza G
J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
